红曲片致高龄患者横纹肌溶解症1例
A Case of Rhabdomyolysis in Elderly Patients Caused by Monascus Piece
DOI: 10.12677/ACM.2022.12121596, PDF,   
作者: 孙浩栋:潍坊医学院研究生院,山东 潍坊;青岛大学附属威海市中心医院心血管内科,山东 威海;宋建广, 曹丙峰*:青岛大学附属威海市中心医院心血管内科,山东 威海
关键词: 红曲片高龄横纹肌溶解症Monascus Piece Old Age Rhabdomyolysis
摘要: 目的:探索红曲制品导致横纹肌溶解的诊治经验。方法:总结威海市中心医院心血管内科2021年6月收治的1例高龄患者服用红曲制品导致横纹肌溶解的诊疗方案。患者因四肢肌肉疼痛、茶色尿5 d入院,入院当天门诊行生化检查示肌酸激酶:33,257 U/L,结合患者临床表现即可诊断为横纹肌溶解,后给予水化、碱化、保肝等处理,结果:患者经治疗后肌酸激酶迅速降低,肌肉酸痛症状也明显减轻,治疗10 d时患者肌酸激酶已降至正常范围,各生化指标基本正常。已无明显不适感后出院。结论:诊断为横纹肌溶解症后,立即解除致病因素和积极水化、碱化成为治疗的关键。
Abstract: Objective: To explore the diagnosis and treatment experience of rhabdomyolysis caused by monas-cus products. Methods: The diagnosis and treatment plan of rhabdomyolysis caused by taking monascus products in an elderly patient admitted to the Cardiovascular Department of Weihai Central Hospital in June 2021 was summarized. The patient was admitted to the hospital due to limb muscle pain and brown urine for 5 days. On the day of admission, the biochemical examination in the outpatient department showed that creatine kinase was 33,257 U/L. Combined with the pa-tient’s clinical manifestations and diagnosis of rhabdomyolysis, the patient was given hydration, al-kalization, liver protection and other treatments. Results: The patient’s creatine kinase rapidly de-creased after treatment, and the symptoms of muscle soreness were also significantly alleviated. After 10 days of treatment, the patient’s creatine kinase had fallen to the normal range, and all bi-ochemical indicators were basically normal. He was discharged after no obvious discomfort. Conclu-sion: After diagnosis of rhabdomyolysis, the key to treatment is to immediately remove the patho-genic factors and actively hydrate and alkalize.
文章引用:孙浩栋, 宋建广, 曹丙峰. 红曲片致高龄患者横纹肌溶解症1例[J]. 临床医学进展, 2022, 12(12): 11079-11083. https://doi.org/10.12677/ACM.2022.12121596

参考文献

[1] 陈斌专, 王妍春. 横纹肌溶解综合症的研究进展[J]. 分子影像学杂志, 2017, 40(4): 474-477.
[2] 陈茜, 吴岳桐, 赵华平, 孙钊, 刘建中, 曹国颖. 药源性横纹肌溶解症病例回顾及文献分析[J]. 临床药物治疗杂志, 2020, 18(5): 55-59.
[3] Anagnostis, P., Paschou, S.A., Goulis, D.G., Athyros, V.G. and Karagiannis, A. (2018) Dietary Manage-ment of Dyslipidaemias. Is There Any Evidence for Cardiovascular Benefit? Maturitas, 108, 45-52. [Google Scholar] [CrossRef] [PubMed]
[4] 郭丽珍, 蒋建清. 脂必妥致横纹肌溶解及急性肾衰1例[J]. 药物流行病学杂志, 2002(6): 334.
[5] 李杰, 黄淑田. 血脂康致高龄病人横纹肌溶解症1例[J]. 中西医结合心脑血管病杂志, 2017, 15(7): 890-891.
[6] Stahl, K., Rastelli, E. and Schoser, B. (2020) A Systematic Review on the Definition of Rhabdomyolysis. Journal of Neurology, 267, 877-882. [Google Scholar] [CrossRef] [PubMed]
[7] 周香珍, 林书发, 何书华. 红曲药学评价研究进展[J]. 中国现代中药, 2016, 18(7): 936-941.
[8] 郑云燕, 李应东. 红曲制剂治疗高脂血症的临床研究[J]. 中医临床研究, 2015, 7(9): 36-37.
[9] 何瑞, 徐志猛, 王来, 李萍, 闻晓东. 他汀相关肌肉症状的研究进展[J]. 药学进展, 2020, 44(4): 303-312.
[10] Sacheck, J.M., Hyatt, J.P., Raffaello, A., et al. (2007) Rapid Disuse and Denervation Atrophy In-volve Transcriptional Changes Similar to Those of Muscle Wasting during Systemic Diseases. The FASEB Journal, 21, 140-155. [Google Scholar] [CrossRef] [PubMed]
[11] Petejova, N. and Martinek, A. (2014) Acute Kidney Injury Due to Rhabdomyolysis and Renal Replacement Therapy: A Critical Review. Critical Care, 18, Article No. 224. [Google Scholar] [CrossRef] [PubMed]
[12] 唐吉刚, 曹秉振. 横纹肌溶解症及其研究进展[J]. 实用医药杂志, 2011, 28(10): 937-939.
[13] Wallach-Kildemoes, H., Stovring, H., Holme Hansen, E., Howse, K. and Pétursson, H. (2016) Statin Prescribing According to Gender, Age and Indication: What about the Benefit-Risk Balance? Journal of Evaluation in Clinical Practice, 22, 235-246. [Google Scholar] [CrossRef] [PubMed]
[14] 赵宇红, 许丹焰, 赵水平, 黄艳红. 中药他汀类药物的研究进展[J]. 长治医学院学报, 2011, 25(1): 74-77.